This resource highlights the real-world impact of the accelerated approval pathway in driving innovation and expanding treatment options for serious and rare conditions. It explains how the pathway has helped improve outcomes while maintaining rigorous FDA oversight.
New Name, Same Commitment to Rare Diseases
The EveryLife Foundation for Rare Diseases has become The RARE Foundation! Read more about our new brand and how it unifies our advocacy work on behalf of the rare disease community.
